Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹318.15Admitted-Finance B 175 EAST OF KAILASH NEW DELHI DELHI 110065 | SOUTH EAST DELHI | DELHI | 110065 | L1 | Admitted-Finance | |
| 2 | L2₹549.41+₹231.26 (72.7%)Admitted-Finance | L2 | Admitted-Finance | |
| 3 | L3₹595.98+₹277.83 (87.3%)Admitted-Finance | L3 | Admitted-Finance | |
| 4 | L4₹846.30+₹528.15 (166.0%)Admitted-Finance | L4 | Admitted-Finance | |
| 5 | L5₹1,330.35+₹1,012.20 (318.2%)Admitted-Finance | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | ALBINO LIFESCIENCES PVT LTD L1 | CONCEPT BIOMEDICAL L5 | GOODLUCK LABORATORIES L8 | Supriya Medihealthcare Pvt. Ltd. L7 | GOYAL PHARMACEUTICALS L10 | SMPL Life Sciences Pvt. Ltd. L11 | MASTODON BIOTECH L6 | Magicine Pharma L4 | AKSHAT PHARMA PRIVATE LIMITED L3 | RICH SURGICAL INDIA PRIVATE LIMITED L2 | SAZ ENTERPRISES L9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Chemo Day Centre | ||||||||||||||
| 1.01 | Inj Pegylated GCSF 6mg | 1,200 | PFS | - | 1,012 ₹1,062.6 Lowest | - | - | 1,398 ₹1,467.9 | 1,249.6 ₹1,312.08 | 1,175 ₹1,233.75 | - | - | - | - |
| 2.01 | Cyclophosphamide 500 mg Inj | 1,650 | VIAL | - | - | 41.04 ₹43.09 Lowest | - | - | 41.8 ₹43.89 | - | - | 145.2 ₹152.46 | - | 49 ₹51.45 |
| 3.01 | Zoledronic acid 5 mg Inj | 150 | Amp/Vial. | - | - | 85.8 ₹90.09 | - | - | 550 ₹577.5 | - | 58 ₹60.9 Lowest | - | - | 66 ₹69.3 |
| 4.01 | Vincristine Sulphate 1mg Inj | 1,200 | VIAL | - | - | 38.08 ₹39.98 | - | - | - | - | - | 37.4 ₹39.27 Lowest | - | 42 ₹44.1 |
| 5.01 | Docetaxel 20mg 0.5ml vial + 1.5 ml Solvent for Inj | 300 | VIAL | 103.5 ₹108.67 Lowest | - | 165.76 ₹174.05 | 470 ₹493.5 | - | 118 ₹123.9 | - | 154 ₹161.7 | 154 ₹161.7 | - | 214.5 ₹225.22 |
| 6.01 | IRINOTECAN 100 MG INJ | 450 | VIAL | - | - | 928.8 ₹975.24 | 680 ₹714 | - | 288 ₹302.4 | - | 286 ₹300.3 Lowest | - | 310.5 ₹326.02 | 996 ₹1,045.8 |
| 7.01 | Paclitaxel 100 mg Inj | 600 | VIAL | 199.5 ₹209.47 | 255 ₹267.75 | 280.8 ₹294.84 | 585 ₹614.25 | 1,189 ₹1,248.45 | 198 ₹207.9 Lowest | 288 ₹302.4 | 308 ₹323.4 | 231 ₹242.55 | 212.75 ₹223.39 | 258 ₹270.9 |
| 8.01 | Cisplatin 50mg Inj | 300 | VIAL | - | - | 352.8 ₹370.44 Lowest | - | - | 475 ₹498.75 | - | - | - | - | 415 ₹435.75 |
Tender Value
₹18.5 L
EMD Value
₹92,520
Closing Date
31 Aug 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 290/1191, 290/814/Chemo Day Centre(Drugs)/IFA RE-119/2026-27 FOR AHRR
2026_ARMY_783935_1
2433/MS/EXP/D 290/1191, 290/814/Chemo Day Centre(Drugs)/IFA RE-119/2026-27
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹92,520
Yes
14 Sept 2026
11 Aug 2026
1 Sept 2026
11 Aug 2026
31 Aug 2026
11 Aug 2026
11 Aug 2026 - 31 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Chemo Day Centre | |||||
| 1.01 | Inj Pegylated GCSF 6mg | 1,200 | PFS | - | - |
| 2.01 | Cyclophosphamide 500 mg Inj | 1,650 | VIAL | - | - |
| 3.01 | Zoledronic acid 5 mg Inj | 150 | Amp/Vial. | - | - |
| 4.01 | Vincristine Sulphate 1mg Inj | 1,200 | VIAL | - | - |
| 5.01 | Docetaxel 20mg 0.5ml vial + 1.5 ml Solvent for Inj | 300 | VIAL | - | - |
| 6.01 | IRINOTECAN 100 MG INJ | 450 | VIAL | - | - |
| 7.01 | Paclitaxel 100 mg Inj | 600 | VIAL | - | - |
| 8.01 | Cisplatin 50mg Inj | 300 | VIAL | - | - |
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
BOQ_878354.xls
BOQ • 0.87 MB
RFP.pdf
Tender Documents • 1.32 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .